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RNA helicases play important roles in RNA metabolism. Human immunodeficiency virus type 1 (HIV-1) does not carry its own RNA helicase,
the virus thus needs to exploit cellular RNA helicases to promote the replication of its RNA at various steps such as transcription, folding and
transport. In this study, we report that knockdown of a DEAD-box protein named DDX24 inhibits the packaging of HIV-1 RNA and thus
diminishes viral infectivity. The decreased viral RNA packaging as a result of DDX24-knockdown is observed only in the context of the Rev/RRE
(Rev response element)-dependent but not the CTE (constitutive transport element)-mediated nuclear export of viral RNA, which is explained by
the specific interaction of DDX24 with the Rev protein. We propose that DDX24 acts at the early phase of HIV-1 RNA metabolism prior to
nuclear export and the consequence of this action extends to the viral RNA packaging stage during virus assembly.
© 2008 Elsevier Inc. All rights reserved.Keywords: HIV-1; RNA helicase; DDX24; Virus infectivity; Viral RNA packagingIntroduction
RNA helicases represent a large family of proteins that are
able to hydrolyze nucleotide triphosphates and use the energy
to alter RNA structure and remodel RNP complex (Cordin et
al., 2006; Tanner and Linder, 2001). All RNA helicases
contain the Walker A and Walker B motifs that are common to
NTPase (Walker et al., 1982). On the basis of the conserved
motifs, RNA helicases are grouped into five families named
SF1 to SF5. The SF1 and SF2 members share five to seven
conserved motifs. Their helicase core domain assumes two
independent RecA-like folds (Caruthers and McKay, 2002).
These helicases function as monomers or dimers (Tuteja and
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They each have one RecA-like motif and form hexamers.
RNA helicases are involved in virtually every phase of RNA
life ranging from transcription, splicing, nuclear export,
translation to degradation (Rocak and Linder, 2004). Of
particular importance are the essential roles of RNA helicases
in the splicing of pre-mRNA and the biogenesis of ribosomes.
Eight RNA helicases have been shown to participate in RNA
splicing and up to twenty are involved in ribosomal assembly
(Linder, 2006; Silverman et al., 2003; Tanner and Linder,
2001).
Viruses also utilize RNA helicases at various stages of their
life cycle. Many viruses carry their own helicases to assist the
synthesis of their genome. These include both DNA viruses
such as herpesvirus (Chattopadhyay et al., 2006), poxvirus
(Jankowsky et al., 2000) and parvovirus (Christensen and
Tattersall, 2002) as well as RNA viruses such as alphavirus
(Gomez de Cedron et al., 1999) and flavivirus (Utama et al.,
2000). Viruses that synthesize their genome within the cell
nucleus tend to exploit cellular helicases and thus do not encode
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one example of this latter virus group.
HIV-1 is a retrovirus and packages two copies of positive-
strand full-length viral RNA per virion (Frankel and Young,
1998). Replication of HIV-1 RNA starts with its reverse
transcription into cDNA followed by its integration into the host
chromosomal DNA to form a provirus. HIV-1 RNA is then
transcribed from proviral DNA by the cellular RNA polymerase
II, matures like all cellular pre-mRNAs including 5′- and 3′-end
modifications as well as splicing, and is exported into the
cytoplasm for translation. It is noted that there are three
processes pertaining to HIV-1 RNA that do not normally occur
to cellular RNA: nuclear export of the intron-containing viral
RNA, packaging of viral RNA into the space-limited interior of
virus particles, and reverse transcription within the cytoplasm.
To remodel the structure of viral RNA while going through
these latter processes, HIV-1 encodes the nucleocapsid (NC)
protein that bears RNA chaperone activity and has been shown
to regulate HIV-1 RNA packaging and viral reverse transcrip-
tion (Levin et al., 2005). Results of recent studies begin to reveal
that HIV-1 also hijacks cellular RNA helicases to facilitate
certain steps of viral RNA replication (Jeang and Yedavalli,
2006).
The first example is DDX3 that has been shown to be an
integral component of the CRM1-Rev–RRE (Rev response
element) complex and regulates the nuclear export of HIV-1
RNA (Yedavalli et al., 2004). DDX1 also interacts with Rev and
RRE, and has an effect on HIV-1 RNA export (Fang et al., 2005,
2004). It is plausible that DDX1 and DDX3 act together to
promote the translocation of viral RNA through the nuclear pore
complex (NPC) by remodeling the viral RNP complex. RNA
helicase A (RHA) has been reported to associate with HIV-1
particles and contributes to viral RNA reverse transcription
(Roy et al., 2006). In addition, RHA promotes HIV-1 gene
transcription by binding to the TAR (Tat transactivation region)
RNA sequence (Fujii et al., 2001; Li et al., 1999). The function
of RHA also extends to the regulation of the replication of other
viruses. For example, RHA associates with the RNA sequence
named the constitutive transport element (CTE) that has been
identified in Mason Pfizer Monkey Virus (MPMV) (Tang et al.,
1997). Together with Tap (Tip-associated protein) and HAP95
(RHA associated protein 95), RHA stimulates the nuclear
export of the CTE-containing viral RNA (Tang andWong-Staal,
2000; Yang et al., 2001). Furthermore, it has recently been
reported that RHA binds to an RNA sequence named PCE (post
transcriptional control element) in the avian spleen necrosis
virus and enhances translation (Hartman et al., 2006). The
multiple functions of RHA in a number of viral processes likely
result from its association with a range of viral and cellular
factors.
In addition to the aforementioned RNA helicases, a few
others have also been suggested to play roles in HIV-1 life
cycle. One example is RH116 whose overexpression leads to
increased levels of unspliced and singly spliced HIV-1 RNA
(Cocude et al., 2003). The Werner syndrome helicase has re-
cently been shown to play an important role in the transactiva-
tion of HIV-1 RNA transcription by the viral Tat protein(Sharma et al., 2007). Results of microarray analysis reveal that
HIV-1 infection changes the expression levels of a few RNA
helicases including DDX9, DDX11, DDX18, DDX21, DDX24
(Krishnan and Zeichner, 2004a,b; van 't Wout et al., 2003).
Moreover, results of proteomic analysis of the purified Gag
complex implicate association of the RHA, DDX18, DDX2l,
and DDX24 RNA helicases with HIV-1 Gag protein (Roy et al.,
2006). However, interaction of these latter RNA helicases with
HIV-1 RNA or proteins and their roles in specific steps of viral
replication remains unclear. In the present study, we provide
evidence that the DDX24 RNA helicase is required for efficient
HIV-1 RNA packaging and thus plays an important role in HIV-
1 replication. This function of DDX24 in viral RNA packaging
has not been observed with the RHA helicase that also interacts
with Gag (Roy et al., 2006), indicating to some extent the
specificity of this role for DDX24.
Results
Knockdown of DDX24 significantly reduces HIV-1 infectivity
We first asked whether DDX24 has a role in HIV-1
replication. To this end, two siRNA oligos siDDX24-1 and
siDDX24-2 were designed to knock down DDX24 (Fig. 1A).
After siRNA treatment, 293T cells were transfected with HIV-1
proviral DNA clone BH10. Results of Western blots showed
that knockdown of DDX24 led to a modest increase in both the
expression of viral Gag protein in cells and the yield of viruses
in the culture supernatants (Fig. 1A). We then measured viral
infectivity by infecting the TZM-bl indicator cells (Wei et al.,
2002). The results showed that viruses generated from DDX24-
knockdown cells were 2- to 3-fold less infectious than those
produced by cells treated with control siRNA (Fig. 1B).
To verify that the decreased viral infectivity results from the
knockdown of DDX24 and not of other cellular proteins, we
mutated the target site of the siDDX24-2 RNA oligo in the
DDX24 cDNA and generated the DDX24-siM DNA construct.
The DDX24-siM mRNA still encodes the wild type DDX24
protein but becomes resistant to the siDDX24-2 RNA oligo.
Indeed, transfection of pDDX24-siM DNA into the siDDX24-
2-treated cells led to increased levels of DDX24 protein and also
restored viral infectivity to wild type levels (Fig. 1C).
We further assessed the effect of DDX24-knockdown on
HIV-1 replication by infecting SupT1 cells. The microRNA30-
based shRNAmir expression vector named LMP was employed
to generate the DDX24-knockdown SupT1 cell line (Figs. 2A
and B). The DDX24-knockdown SupT1 cells exhibited the
same morphology and similar growth rate as the control cells.
We infected the control and the DDX24-knockdwon SupT1
cells with wild type HIV-1 and monitored viral growth by
measuring the levels of viral reverse transcriptase activity in the
culture fluids. The results of Fig. 2C show lower levels of virus
production by the DDX24-knockdown SupT1 cells throughout
the infection period with a 5-fold decrease by day 13. This data
supports the results of the one-round infection assay shown in
Fig. 1B. Most of the cells died as a result of HIV-1 infection
after day 15 and tissue culture was thus discontinued. Taken
Fig. 1. DDX24-knockdown leads to decreased viral infectivity. (A). Effects of DDX24-knockdown on the expression of HIV-1 Gag protein and the production of virus
particles. Levels of DDX24, Gag and β-actin in the lysates of 293T cells were assessed by Western blots. The amount of viruses in the culture supernatants was either
determined in Western blots using anti-HIV p24 antibodies or by ELISA. Results shown represent one of the three independent transfection experiments. (B). Effect of
DDX24-knockdown on viral infectivity. Viruses equivalent to 5 ng of p24(CA) were used to infect the TZM-bl indicator cells. Levels of firefly luciferase activity were
measured 48 h after infection and the results are used to calculate viral infectivity. The infectivity of viruses from 293T cells that had been treated with control siRNA
oligos was arbitrarily set as 100. The data shown represent three independent infections using virus stocks prepared by three independent transfection experiments. The
standard deviations are shown. The p values were calculated using the T-Test program (two-sample, two-tail, assuming equal variances). The asterisks denote
pb0.001. (C). Rescue of DDX24 expression in cells treated with the siDDX24-2 RNA oligos. The pDDX24-siM DNA was co-transfected with HIV-1 cDNA
BH10 into 293T cells that had been treated with either the control siRNA or the siDDX24-2 RNA. The expression levels of DDX24 were monitored by Western blots.
The infectivity of viruses was determined by infecting the TZM-bl indicator cells.
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restricts HIV-1 replication.
DDX24-knockdown diminishes HIV-1 RNA packaging
We next measured the levels of virion-associated viral RNA
in an attempt to identify the viral defects caused by DDX24-
knockdown. Viral RNA was prepared from viruses containing
15 ng p24(CA) antigen and the RNA was further converted
viral cDNA by reverse transcription using the p960-A primer
that binds to the MA coding region, followed by regular PCR
to amplify the viral DNA fragment spanning nucleotide
positions 675 to 960. In the control experiment, no viral
DNA signal was amplified directly from viral RNA samples
(Fig. 3A, top, lanes 1–3), therefore ruling out contamination
by viral plasmid DNA used in transfection. The results of RT-
PCR revealed lower levels of viral RNA in the siDDX24-1 and
siDDX24-2 virus samples than those in the control (Fig. 3A,
lanes 4–6). This reduction was further quantified by real-time
PCR to 3- to 4-fold for the DDX24-knockdown samples
(Fig. 3A, bar graph).HIV-1 genomic RNA is packaged into virus particles in the
dimeric form (Paillart et al., 2004b; Russell et al., 2004). We
were thus interested to know whether DDX24-knockdown also
affects HIV-1 RNA dimerization in addition to the adverse
effect on viral RNA packaging. To answer this question, viral
RNA was extracted from virus particles, treated at a series of
temperatures in a buffer containing 100 mM NaCl, followed by
electrophoresis in 0.9% native agarose gels. The results of
Northern blots showed that viral RNA was detected as dimers
regardless of whether the samples were obtained from the
control or the DDX24-knockdown experiments (Fig. 3B, lanes
1, 5, and 9). Furthermore, all viral RNA dimers were dissociated
to monomers between 45 °C and 50 °C (Fig. 3B), suggesting
that DDX24-knockdown does not change the thermo-stability
of HIV-1 RNA dimers. It was also noted that the total levels of
virion-associated viral RNA in the DDX24-knockdown sam-
ples were lower than those in the control (Fig. 3B), which is
consistent with the real-time RT-PCR data in Fig. 3A.
We also studied whether the defective HIV-1 RNA
packaging is a result of altered expression of viral RNA in
cells. The Northern blot data showed similar levels of viral
Fig. 2. HIV-1 replication is attenuated in the DDX24-knockdown SupT1 cells.
(A). Illustration of the LMP vector and the hairpin sequence of the LMP-
shDDX24 DNA. This microRNA is designed to target the DDX24 mRNA at
nucleotide positions from 1330 to 1348. The mature miRNA sequence is shown
in lowercase letters. (B). Western blots measuring levels of DDX24 protein in
the LMP-shCon and the LMP-shDDX24 SupT1 cells. (C). Growth of HIV-1 in
the LMP-shCon and the LMP-shDDX24 SupT1 cells. The culture fluid samples
were collected at various time intervals, levels of reverse transcriptase activity
were measured to monitor viral growth. Similar results were obtained in two
independent infection experiments.
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control and in the DDX24-knockdown 293T cells that had been
transfected with the BH10 DNA (Fig. 3C). Taken together, we
conclude that knockdown of DDX24 adversely affects HIV-1
RNA packaging and as a result, restricts viral replication.
DDX24 interacts with HIV-1 Gag and Rev proteins
With the aim to gain insight into the mechanism underlying
the involvement of DDX24 in HIV-1 RNA packaging, we
studied the interaction of DDX24 with viral factors. Results of
our previous proteomic analysis of the Gag complex reveal
DDX24 as a potential Gag-associated cellular factor (Roy et al.,
2006). We have now immunoprecipitated the Gag-Flag protein
and assessed the DDX24 protein in the precipitates by Western
blots using anti-DDX24 antibodies. The results showed thatDDX24 was co-immunoprecipitated with Gag (Fig. 4A). Using
a panel of Gag deletions, we were able to show that the NC
sequence was required for Gag–DDX24 interaction (Fig. 4A).
When cell lysates were treated with RNase A prior to the
immunoprecipitation procedure, DDX24 was not co-precipi-
tated with Gag, indicating the RNA-mediated nature of Gag–
DDX24 interaction (Fig. 4B). It is known that the yeast homolog
of DDX24 named MAK5 participates in the biogenesis of the
60S large ribosome subunit and is located within the nucleoli
(Bernstein et al., 2006; Zagulski et al., 2003). Consistently,
DDX24 was also seen within the nucleoli by indirect immuno-
fluorescence staining (data not shown). Although HIV-1 Gag
protein was mainly located within the cytoplasm, a minute
amount was frequently seen within the nucleus (data not shown).
We speculate that the interaction between the DDX24 and the
Gag protein takes place within the nucleus.
The nucleolus-localization of DDX24 prompted us to
investigate whether DDX24 interacts with the HIV-1 Rev
protein that is also predominantly located within the nucleoli
(Pollard and Malim, 1998). As expected, the endogenous
DDX24 protein displayed significant co-localization with Rev
(Fig. 4C). The interaction between DDX24 and Rev was further
investigated by immunoprecipitation experiments. We first
transfected 293T cells with the Rev-His DNA that expresses the
Rev protein with the 6xhistidine tag (Invernizzi et al., 2006).
The Rev-His protein was purified from cell lysates using the
nickel-charged resin and assessed by Western blots. The results
showed that the endogenous DDX24 was co-purified with the
Rev-His protein (Fig. 4D). In accordance with this observation,
immunoprecipitation of the DDX24-Flag protein also led to co-
precipitation of the Rev protein (Fig. 4E). Interestingly, when
the cell lysates were first treated with RNase A prior to
immunoprecipitation, a significant amount of Rev protein was
still pulled down together with DDX24-Flag (Fig. 4F). Thus,
interaction of DDX24 and Rev is partially resistant to RNase
treatment. Together, these data suggest the association of
DDX24 with both Gag and Rev proteins, indicative that this
RNA helicase is incorporated into the Rev–viral RNA or the
Gag–viral RNA complexes likely at different stages of viral
RNA metabolism, thus has the opportunity to actively modify
the viral RNA conformation and regulate viral RNA functions
including encapsidation into virus particles.
Knockdown of DDX24 moderately increases the nuclear export
of unspliced HIV-1 Gag-Pol RNA
The interaction with Rev suggests a role of DDX24 in the
function of Rev. In order to test this possibility, we assessed the
effect of DDX24-knockdown on Rev-dependent expression of
chloramphenicol acetyltransferase (CAT) from the pDM128
reporter DNA (Hope et al., 1990). The pGL3-Luc plasmid DNA
was also co-transfected and levels of firefly luciferase activity
were used as an internal control to correct transfection
efficiency. The results showed that the Rev protein enhanced
the level of CAT expression by 21-fold in the control cells as
opposed to a 32-fold increase in the DDX24-knockdown cells
(Fig. 5A). However, statistical analysis of the data indicates that
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knockdown promotes the function of Rev only to a marginal
extent if there is any. We further investigated this subject by
measuring the Rev/RRE-dependent expression of Gag from the
GPV-RRE DNA in the DDX24-knockdown cells. The results of
Fig. 5B show that the GPV-RRE DNA produced higher levels
of Gag protein in the DDX24-knockdown cells than in the
control, which is consistent with a 2-fold increase of viral RNA
expression in the knockdown cells (Fig. 5C, lanes 1 and 2). To
answer whether DDX24-knockdown affects the nuclear export
of viral RNA, RNA was extracted from the cytosol and the
nuclear fractions followed by Northern blot analysis. As
compared to the 2-fold increase of total viral RNA due to
DDX24-knockdown, a 2.9-fold increase was measured for the
levels of viral RNA in the cytoplasm (Fig. 5C, lanes 3 and 4).
These data together suggest that knockdown of DDX24
moderately increases the Rev-dependent nuclear export of
HIV-1 Gag-Pol RNA. Similar experiments were performed with
the GPV-CTEx4 DNA that expresses viral RNA via the CTE/
Tap mediated nuclear export pathway (Wodrich et al., 2000).
The results showed that knockdown of DDX24 modestly
inhibited the CTE-mediated nuclear export of HIV-1 RNA
(Fig. 5C). Therefore, DDX24 exhibits a specific though mod-
erate effect on Rev-mediated nuclear export of HIV-1 RNA.
Knockdown of DDX24 restricts packaging of viral RNA that is
exported by the Rev-dependent pathway
It has recently been reported that, in addition to the export of
viral RNA from the nucleus, Rev also warrants efficient pack-
aging of viral genomic RNA into virus particles (Brandt et al.,
2007). We speculate that this latter function of Rev may benefit
from the associated cellular factors such as DDX24 that was
shown herein to interact with Rev and its knockdown led to
reduced viral RNA packaging. To further test this hypothesis,
we measured the packaging of viral RNA that is expressed from
the GPV-RRE and the GPV-CTEx4 DNA. Since both DNA
vectors bear the intact 5′ UTR of HIV-1 RNA (Fig. 5B), theFig. 3. DDX24-knockdown inhibits HIV-1 RNA packaging. (A). Viral RNAwas
extracted from viruses equivalent to 15 ng of p24(CA), followed by treatment
with DNase I and reverse transcription using the p960-A primer. To rule out the
possible contamination by plasmid DNA, the viral RNA samples were directly
assessed by PCR (lanes 1–3). The reverse transcribed samples were analyzed by
regular PCR using primers p675-S/p960-A (lanes 4–6). Dilutions of the BH10
DNA were amplified as standards (lanes 7–9). The reverse transcription
products were further quantified by real-time PCRwith the same primers. Levels
of viral RNA in the control experiments are arbitrarily set as 100. Data shown in
the bar graph are the average of three real-time RT-PCR assays measuring levels
of viral RNA prepared from three independent virus stocks. Copies of the HIV-1
full-length RNA from one real-time PCR experiment are also shown. The
asterisks denote pb0.001. (B). DDX24-knockdown does not affect HIV-1 RNA
dimerization. Viral RNAwas extracted from viruses equivalent to 200 ng of p24
(CA) and incubated at 40 °C, 45 °C, 50 °C or 55 °C prior to electrophoresis and
Northern blots. (C). Expression of viral RNA in the control and DDX24-
knockdown 293T cells. Total cellular RNA was extracted and an amount of
20 μg was analyzed in Northern blots using the [α-32P] labeled HIV-1 DNA
probes (nucleotide positions 1 to 2000). GAPDH mRNA was detected as an
internal control (Ferraiuolo et al., 2005).RNA transcribed from both vectors should be recognized by
viral Gag protein with equal efficiency. Viral RNA was ex-
tracted from viruses of equal amounts of p24(CA) and quan-
tified by real-time RT-PCR. The results showed that knockdown
of DDX24 inhibited packaging of viral RNA into the GPV-RRE
viruses by approximately 2-fold (Fig. 5D), which supports the
results obtained with the full-length HIV-1 proviral DNA
(Fig. 3). The GPV-CTEx4 viruses carried 2- to 3-fold less viral
RNA than the GPV-RRE viruses (Fig. 5D). This result is con-
sistent with the previous finding that Rev-mediated nuclear
Fig. 4. Interaction of DDX24 with HIV-1 Gag and Rev proteins. (A). DDX24 was co-immunoprecipitated with Gag. Domain structures of the wild type hGag-Flag and
the hGag mutants are illustrated. D449-Flag, D378-Flag, D278-Flag, and D133-Flag lack the p6, NC-p6, CA(CTD)-NC-p6, and CA-NC-p6 domains, respectively. The
293T cells were transfected with the wild type or the truncated versions of the Gag-Flag DNA followed by purification with the anti-Flag affinity gel. The eluted
samples were subjected to Western blots using anti-DDX24 or anti-Flag antibodies. (B). DDX24-Gag interaction is sensitive to RNase A treatment. Cell lysates were
treated with RNase A (100 μg/ml) prior to immunoprecipitation with anti-Flag affinity gel. The effectiveness of RNase A treatment was assessed by determining the
levels of ribosomal RNA. (C). DDX24 colocalizes with Rev. HeLa cells were transfected with the Rev-RFP DNA. The endogenous DDX24 was immuno-stained with
anti-DDX24 antibody. (D). The endogenous DDX24 is pulled down with Rev-His. The Rev-His protein was purified from 1 mg cell lysates with the nickel-charged
agarose. The total cell lysates (50 μg) and the purified samples were subjected to Western blots using antibodies either against DDX24 or Rev. (E). Rev is co-
immunoprecipitated with DDX24-Flag. The 293T cells were transfected with the Rev and the DDX24-Flag DNA. The DDX24-Flag protein was immunoprecipitated
with the anti-Flag M2 affinity gel. The Rev and DDX24-Flag proteins were detected with anti-Rev and anti-Flag antibodies, respectively. (F). The interaction of
DDX24-Flag and Rev is partially resistant to RNase A treatment. The total cell lysates with DDX24-Flag and Rev proteins were treated with RNase A (100 μg/ml) for
30 min at 37 °C prior to the immunoprecipitation procedure using anti-Flag antibodies. Levels of the DDX24-Flag and Rev proteins in the precipitated samples were
assessed by Western blots. Total cellular RNAwas extracted from cell lysates that had been treated or not treated with RNase A and separated by electrophoresis in 1%
agarose gels.
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RNA than the CTE-mediated pathway (Brandt et al., 2007).
Interestingly, knockdown of DDX24 did not further reduce thelevels of viral RNA associated with the GPV-CTEx4 viruses
(Fig. 5D). These data suggest that the DDX24 protein exerts its
effect on HIV-1 RNA packaging only in the context of the Rev-
Fig. 5. Effects of DDX24-knockdown on the Rev-dependent gene expression and HIV-1 RNA packaging. (A). DDX24-knockdown stimulates Rev-dependent
expression of the CATenzyme. On the top is the schematic illustration of the pDM128 DNA (Hope et al., 1990). The pGL3-Luc plasmid DNA, which expresses firefly
luciferase from the SV40 promoter, was included in the co-transfection. The levels of firefly luciferase were used as internal control to adjust the CAT activity. Levels
of CAT activity in the presence of Rev expression were divided by the levels that were expressed from the pDM128 DNA alone. The results are used to represent the
fold of activation by the Rev protein. The standard deviations are shown, the p value is calculated as 0.1. (B). Structures of the GPV-RRE and GPV-CTEx4 DNA are
depicted. Both DNA constructs contain HIV-1 RNA sequence spanning nucleotide positions 1 to 5337 (referring to the transcription initiation site). The RRE or the
CTEx4 cassette is inserted immediately downstream of the HIV-1 sequence. Levels of viral Gag proteins were assessed by Western blots using anti-HIV p24
antibodies. (C). Knockdown of DDX24 promotes the nuclear export of HIV-1 RNA. RNAwas extracted from the total cell lysates, the cytosol or the nucleus, followed
by Northern blots probing for HIV-1 RNA and GAPDHmRNA. The relative levels of viral RNA from each cellular fraction were calculated and are shown with those
from the control cells as 100. (D). DDX24-knockdown inhibits viral RNA packaging into the GPV-RRE viruses. Viral RNAwas extracted from viruses equivalent to
15 ng of p24(CA), and quantified in real-time RT-PCR. Levels of viral RNA associated with the GPV-RRE viruses produced from control siRNA-treated cells are
arbitrarily set as 100 and the results are shown in the bar graph. The calculated p values are indicated (⁎denotesb0.01). Copies of viral RNA from one real-time RT-
PCR experiment are also presented.
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association with the Rev protein.
Discussion
We previously attempted to identify Gag-associated cellular
factors by proteomic analysis and the results unveiled four RNA
helicases named RHA, DDX18, DDX21 and DDX24 (Roy
et al., 2006). We now demonstrate that DDX24 contributes to
HIV-1 replication by promoting the packaging of viral RNA
into virus particles. This role of DDX24 in viral RNA packaging
is likely specific since we did not observe any effect from RHA-
knockdown in this regard (Roy et al., 2006). The function of
DDX18 and DDX21 in viral RNA packaging was not pursuedmainly because of the significantly reduced levels of viral RNA
expression in cells with knockdown of either DDX18 or DDX21
(data not shown), which renders it difficult to accurately cal-
culate the efficiency of viral RNA packaging.
DDX24 bears the nine motifs that are conserved in all
DEAD-box proteins and is thus recognized as a putative RNA
helicase. In light of this feature, DDX24 is speculated to
regulate the function of viral RNA by remodeling the viral RNP
complexes. One question is how DDX24 gains access to HIV-1
RNP, an issue that applies to almost all RNA helicases in terms
of how their substrate specificity is determined. It is currently
unclear whether DDX24 directly binds to HIV-1 RNA, but we
did observe that DDX24 interacted with HIV-1 Rev protein that
specifically recognizes a stretch of 234 nucleotides viral RNA
260 J. Ma et al. / Virology 375 (2008) 253–264sequence within the env coding region termed RRE and directs
the nuclear export of unspliced and singly spliced viral RNA
(Pollard and Malim, 1998). In addition, DDX24 was also co-
immunoprecipitated with viral Gag protein (Fig. 4A). Con-
sidering the specific interactions of Rev and Gag with viral
RNA, we propose that DDX24 represents a component of the
viral RNP complex and is able to rearrange viral RNA structures
by exercising its helicase activity. In line with the predominant
nucleolus-localization of DDX24, this RNA helicase is ex-
pected to exert its effect on viral RNA prior to the nuclear export
event. Molecular details of this function of DDX24 remain to be
investigated.
Knockdown of DDX24 affects two steps in viral RNA
replication: the Rev-dependent nuclear export and the packaging
into virus particles. As opposed to the requirement of DDX1 and
DDX3 for Rev's function (Fang et al., 2005, 2004; Yedavalli
et al., 2004), depletion of DDX24 moderately promotes the
export of the Gag-Pol viral RNA (Fig. 5C). One explanation is
that DDX24 reinforces the sequestration of Rev within the
nucleoli. With decreased levels of DDX24, more Rev can shuttle
between the nucleus and the cytoplasm and export more viral
RNA. However, considering the moderate effect of DDX24-
knockdown on HIV-1 RNA export, DDX24 may not be consi-
dered as an important helicase player in the Rev-Crm1 pathway.
The specific HIV-1 RNA packaging is determined by the
high affinity of the NC domain of Gag precursor for viral RNA
packaging signal termed ψ that is located within the 5′ UTR
(Berkowitz et al., 1996; D'Souza and Summers, 2005). Up to
date, little is known regarding where and when HIV-1 RNA
packaging starts in cells. A recent study showed that HIV-1 Gag
protein interacts with viral RNA at the perinuclear/centrosomal
site, indicating that the selection of HIV-1 RNA by Gag initiates
immediately following the export of viral RNA from the
nucleus (Poole et al., 2005). In addition, the nuclear history of
HIV-1 RNA also has an impact on its packaging into virus
particles. This latter idea is highlighted by the involvement of
Rev in this packaging process (Swanson and Malim, 2006;
Swanson et al., 2004). It has been reported that the RRE-
containing lentivector RNA is spread among cells at a much
higher frequency upon HIV-1 infection than lentiviral vector
RNA that does not bear the authentic RRE sequence (Lucke
et al., 2005). Recent studies demonstrated that this is because
the RRE-containing RNA is far more efficiently incorporated
into HIV-1 particles (Brandt et al., 2007; Lucke et al., 2005).
Yet, the underlying mechanism is still unclear. DDX24 may
represent one important element involved in this mechanism
considering that DDX24 binds to Rev and DDX24-knockdown
inhibits the packaging of RRE-containing but not the CTE-
containing viral RNA (Fig. 5).
DDX24 likely exerts its effect on HIV-1 RNA packaging by
modifying viral RNA structures such as assisting the HIV-1 5′
UTR RNA to switch between two mutually exclusive
conformations called the branched multi-hairpin (BMH) and
the long-distance interaction (LDI) (Abbink and Berkhout,
2003; Berkhout et al., 2002; Ooms et al., 2004a,b). The BMH
conformation properly presents the dimerization initiation
signal and the RNA packaging signal, and thus is competentfor dimerization and packaging (Berkhout et al., 2002; Ooms
et al., 2004a). In contrast, these viral RNA signals are hidden in
the LDI conformation. Interestingly, in an attempt to decipher
the secondary structures of HIV-1 5′ UTR RNA by chemical
modification assays, it has been discovered that in infected cells,
HIV-1 RNA is not engaged in long range interactions including
the LDI model (Paillart et al., 2004a). It is further suggested that
HIV-1 RNA may initiate the dimerization process as early as
right after transcription in the nucleus (Sinck et al., 2007).
Considering the tendency of HIV-1 RNA to assume either the
BMH or LDI conformation in vitro, it is arguable that cellular
factors promote the folding of the BMH structure. DDX24 may
represent a cellular factor of this kind. It will not be surprising if
additional nuclear RNA helicases are discovered to modulate
the function of HIV-1 RNA considering that the majority of
cellular RNA helicases are located within the nucleus and that
HIV-1 RNA needs to assume the right conformation when it
leaves the nucleus. In support of this view, we recently reported
the multiple effects of the overexpression of the DHX30
helicase on HIV-1 gene expression and viral RNA packaging
(Zhou et al., in press). In contrast to the positive role of DDX24
in HIV-1 RNA packaging, overexpression of DHX30 leads to
decreased levels of virion-associated viral RNA and hence
blocks viral replication.
In summary, our data reveal an important role of DDX24 in
HIV-1 RNA packaging. This function of DDX24 is attributed to
its interaction with HIV-1 Gag and Rev proteins. Our finding
further strengthens the influence of the nuclear history of HIV-1
RNA on its subsequent activities within the cytoplasm.
Materials and methods
Plasmid DNA constructs
The BH10 infectious HIV-1 cDNA clone was used in the
following experiments. The pRev and pRev-His DNA con-
structs were kindly provided by Dr. Cedric F Invernizzi
(Invernizzi et al., 2006). The pGL3-Luc plasmid DNA is a gift
from Dr. Chris M. Brown (Rackham and Brown, 2004). To
generate the pGPV-RRE and the pGPV-CTEx4 DNA, the RRE
and the CTEx4 cassettes were amplified from HIV-1 cDNA
BH10 and the MPMV cDNA using primer pairs RRE-S (5′-
GAC TTC TAG ACC TCG AGG CGG CCG CGT AGC ACC
CAC CAA GGC AAA G-3′) and RRE-A (5′-GAC TGG GCC
CTA GCATTC CAA GGC ACA GCA G-3′), CTE-S (5′-GAC
TTC TAG ACC TCG AGG CGG CCG CGA TCC ACT AGT
ACT AGA CCA C-3′) and CTE-A (5′-GAC TGG GCC CGC
CGC TCT AGC TGA TCA ACA C-3′), respectively. These
DNA fragments were first inserted into the XbaI/ApaI sites of
pcDNA3.1, followed by insertion at the BamHI/XhoI sites of the
HIV-1 sequence spanning nucleotide positions 1 to 5337
(referring to the first nucleotide of the 5′ R region) that was
amplified using primer pair Bam-454-S (5′-GAT CGG ATC
CGG TCT CTC TGG TTA GAC CAG-3′) and Sal-A (5′-CTA
TTC TGC TAT GTC GAC ACC C-3′).
The hGag sequence was amplified by PCR from the
pVRC_3900 vector (Huang et al., 2001) (kindly provided by
261J. Ma et al. / Virology 375 (2008) 253–264Dr. Gary J. Nabel) using primer pair hGag-S (5′-GAC TGATAT
CAT GGG CGC CCG CGC CAG CGT G-3′)/hGag-A (5′-GAC
TTC TAG ATTACT TAT CGT CGT CAT CCT TGTAAT CTT
GTG ACG AGG GGT CGC TGC C-3′). The hGag-A primer
contains the Flag sequence that is attached to the C-terminus of
hGag. The amplified DNA fragment was inserted at the EcoRV/
XbaI sites of pcDNA3.1 (Invitrogen), and the plasmid thus
generated is named phGag-Flag. The D449-Flag, D378-Flag,
D278-Flag and D133-Flag mutants were created using the
following primers:
D449: 5′-GCATCT CGA GAA AAT TCC CTG GCC TTC
CCT TG-3′;
D378: 5′-GCATCT CGA GCATGATGG TGG CGC TGT
TGG-3′;
D278: 5′-GCATCT CGA GGTACATGC GCA CGATCT
TGT TC-3′;
D133: 5′-GCATCT CGA GGT AGT TCT GGC TCA CCT
GG-3′.
The DDX24 cDNA clone was purchased from Invitrogen
(clone ID 4303448). Primers DDX24-S (5′-CAC GCG GCC
GCATGA AGT TGA AGG ACA CAA AAT CAA GG-3′) and
DDX24-A (5′-CCA TCT AGA TTA AAG AGC GTA ATC
TGG AAC ATC GTA TGG GTA ATT TGC ACT TGT ACT
TGG CTG TGG-3′) were used to amplify the cDNA of DDX24
and the PCR product was inserted into the expression vector
pcDNA3.1. The DDX24-siM DNA contains the mutations
G2280A/A2283T/C2286A/T2289C/T2295A at the siDDX24-2
target site (nt 2277 to 2295). It was generated using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene) with
primers 5′-GTG GTC AAG GAA CGT ATA CGC TTA GCA
CGA CAG ATT GAG-3′ and 5′-CTC AAT CTG TCG TGC
TAA GCG TAT ACG TTC CTT GAC CAC-3′.
The LMP-shDDX24 DNA was engineered by inserting the
XhoI–EcoRI DNA fragment of 110 bp from vector pSM2c (clone
IDV2HS_244226, OpenBiosystems) into the LMP vector (Open
Biosystems). TheRev-RFPDNAwas constructed by inserting the
Rev and RFP coding sequences into the pcDNA3.1 (Invitrogen)
expression vector. The Rev sequence was amplified with primers
5′-GACTGATATCACCATGGCAGGAAGAAGCGGAGA
CAG CG-3′ (with the EcoRV site) and 5′-GAC ACT CGA GTT
CTT TAG TTC CTG ACT CCA ATA C-3′ (with the XhoI site),
RFP was amplified with 5′-GAC TGG GCC CTA CAG GAA
CAG GTG GTG GCG-3′ (with the XbaI site) and 5′-GAC TGG
GCC CTA CAG GAA CAG GTG GTG GCG-3′ (with the ApaI
site).
Knockdown of DDX24 protein
siRNA oligos 5′-CCU GGU CCA AAC UGC UCC ATT-3′
(siDDX24-1, targeting nt positions 537 to 555 (NM_020414)),
5′-GGA GCG AAU CCG UUU AGC UTT-3′ (siDDX24-2,
targeting nt positions 2277 to 2295 (NM_020414)), and control
siRNA oligos (catalogue number AM4635) were purchased from
Ambion. Transfection of siRNA (at 40 nM) was performed with
Lipofectamine 2000 (Invitrogen). To generate stable DDX24-knockdown cell lines, the LMP-shDDX24 DNA was first
transfected into the LinX packaging cells (Open Biosystems).
Viruses in the supernatants were used to infect SupT1 cells.
Puromycin (Sigma) was added to the culture at a final concen-
tration of 2 μg/ml 24 h after infection. The positively infected
cells were selected in three weeks following six successive
passages. Puromycin-resistant cells were further assessed with
flow-cytometry for GFP expression to ascertain the stable inte-
gration of the LMP vector. Knockdown efficiency was evaluated
in Western blots using rabbit anti-DDX24 antibodies (Novus
Biologicals).
Immunofluorescence staining
HeLa cells were transfected with the Rev-RFP DNA. Twenty-
four hours after transfection, cells were fixed with 3.7%
formaldehyde at room temperature for 10 min, followed by
permeabilization with 0.1% Triton-X100 for 10 min. After
washing with 1× PBS, cells were incubated in 5% milk at room
temperature for 1 h prior to adding the Rabbit anti-DDX24
antibodies (1:150 dilution, Novus Biologicals). Cells were
subsequently stained with Alexa fluor 488-conjugated goat
anti-rabbit secondary antibodies (1:500 dilution, Invitrogen).
Images were recorded using LSM 5 PASCAL laser scanning
confocal microscope (Carl Zeiss).
Immunoprecipitation
The DDX24-Flag or Gag-Flag proteins were immunopreci-
pitated with anti-Flag antibodies. After washing with 1×
phosphate buffered saline, transfected cells were lysed in a
buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, and protease inhibitor cocktails
(Roche Diagnostics), followed by three times freeze-thaw
treatment. The cell debris was pelleted by spinning at
13,000 rpm in an eppendorf centrifuge at 4 °C. One mg of the
clarified cell lysates was incubated with 30 μl of the anti-Flag
M2 affinity gel (Sigma) at 4 °C for 16 h. After washing in TBS
(50 mM Tris (pH 7.4), 150 mMNaCl) for three times, the bound
DDX24-Flag proteins were eluted with 100 μg/ml Flag peptides
in TBS. The Rev-His proteins were purified using the nickel-
charged agarose. 293T cells were transfected with the pRev-His
DNA and lysed in the buffer containing 50 mM NaH2PO4,
5 mM Tris–HCl (pH 8.0), 300 mM NaCl, 0.05% Tween-20,
10 mM β-mercaptoethanol, and protease inhibitor cocktails
(Roche Diagnostics). After clarifying at 13,000 rpm in an
eppendorf centrifuge, the cell lysates were incubated with 30 μl
of the Ni-NTA agarose (Qiagen) at 4 °C for 2 h. After extensive
washing with 50 mM NaH2PO4, 5 mM Tris–HCl (pH 8.0),
300 mM NaCl and 10 mM imidazole, the bound Rev-His
proteins were eluted with 50 mM NaH2PO4, 5 mM Tris–HCl
(pH 8.0), 300 mM NaCl and 250 mM imidazole.
Measuring viral infectivity in one-round infection assay
Amounts of HIV-1 were determined by measuring levels of
viral p24(CA) antigen using the Vironostika HIV-1 Antigen
262 J. Ma et al. / Virology 375 (2008) 253–264Microelisa System (Biomerieux, The Netherlands). Viruses
equivalent to 5 ng p24(CA) were used to infect 4×104 TZM-bl
cells in a 24-well plate. TZM-bl are HeLa cells that bear the
CD4, CXCR4, and CCR5 cell surface markers and express
firefly luciferase upon HIV-1 infection (Wei et al., 2002). Cells
were collected 48 h post infection and luciferase activity was
measured using the Luciferase Assay System (Promega).
CAT (chloramphenicol acetyltransferase) assay
The 293T cells were seeded in 6-well plates one day prior to
transfection with 200 ng of the pDM128 DNA alone or together
with 50 ng of the Rev DNA. Cells were collected 48 h after
transfection and lysed in 250 mM Tris–HCl (pH 7.5) by freeze
and thaw. The CAT activity was measured in a reaction mixture
containing 50 μl cell lysates, 30 μM [14C] chloramphenicol (at
50 μCi/ml, Amershan), 0.3 mg/ml n-butyryl coenzyme-A
(Sigma) at 37 °C for 1 h. The reaction products were extracted
with ethyl acetate, separated on the TLC plate, detected by
exposure to phosphor screen and quantified using the Storm840
phosphor imager (Amersham).
Viral RNA analysis
Levels of viral RNA in cells were assessed by Northern blots
as previously described (Roy et al., 2006). Briefly, transfected
cells were washed with 1× phosphate buffered saline and
directly solubilized by Trizol (Invitrogen). RNA was extracted
in accordance with the manufacturer's instruction. To prepare
the cytoplasmic and nuclear fractions, cells were first lysed in a
buffer containing 0.5% Nonidet P-40, 50 mM Tris–HCl (pH
8.0), 100 mM NaCl, and 5 mM MgCl2. After spinning at
5000 rpm in an eppendorf centrifuge at 4 °C for 30 min, the
supernatants were collected and represented the cytoplasmic
fraction. The pellets were washed twice with lysis buffer and
represented the nuclear fraction. RNAwas extracted from these
two fractions using the Trizol-LS reagent (Invitrogen).
Levels of virion-associated viral RNA were determined by
real-time RT-PCR or by native Northern blots. RNA was first
extracted from viruses using Trizol-LS (Invitrogen), followed by
DNase I digestion at 37 °C for 15 min to remove any con-
taminating plasmid DNA. DNase I was inactivated by incubation
at 65 °C for 10 min. The effectiveness of DNase I treatment is
tested by amplifying the treated RNA samples in PCR with the
primers p675-S (5′-CCA GAGGAG CTC TCT CGA CGCAG-
3′) and p960-A (5′-GTA TTT GTC TAC AGC CTT CTG-3′).
This primer pair amplifies HIV-1 cDNA sequence spanning
nucleotides 675 to 960. Subsequent to reverse transcription of
viral RNA with primer p960-A, levels of viral cDNA were
measured by real-time PCR with primers p675-S/p960-A using
the LightCycler FastStart DNAMaster SYBRGreen 1 kit (Roche
Diagnostics) in the light cycler real-time PCR machine (Roche
Diagnostics). The standard curve was created with a series of
diluted HIV-1 cDNA including 102, 5×102, 103, 5×103, 104,
5×104 and 105 copies.
Native Northern blots were performed as previously
described (Russell et al., 2003). Briefly, HIV-1 particles wereharvested by ultracentrifugation at 35,000 rpm for 1 h using the
SW41 rotor. The virus pellets were suspended in the TN buffer
(10 mM Tris–HCl (pH 7.5) and 100 mMNaCl). The amounts of
viruses were determined by measuring viral p24 levels in
ELISA. After treatment with protease K at 37 °C for 20 min in a
buffer with 100 μg/ml protease K, 0.1% SDS, 2 mg/ml yeast
tRNA, 10 mM Tris–HCl (pH 7.5) and 100 mM NaCl, viral
RNA was prepared by sequential extraction with phenol:
chlorophorm:isoproponal (25:24:1) and chlorophorm. Follow-
ing precipitation in 70% ethanol with 0.3 M NaOAc (pH 5.2),
viral RNA was suspended in RNA storage buffer containing
1 mM sodium citrate (Ambion). After incubation for 10 min at a
series of temperatures (40 °C, 45 °C, 50 °C and 55 °C) in the
presence of 100 mM NaCl, viral RNA was subjected to
electrophoresis in 0.9% agarose gels at 4 °C, 100 V for 4 h. Viral
RNA was subsequently transferred onto the nylon membranes
and detected with [α-32P] labeled HIV-1 DNA probes.
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